---
canonical_url: https://www.stockexpertai.com/tr/earnings/jnj
last_updated: 2026-07-18T06:12:50.382Z
---

# Johnson & Johnson (JNJ) Q1 FY2027 Bilanço Önizleme

> Bu içerik FMP canlı veri + Q2 FY2026 earnings call transcript ile otomatik üretildi. Üretim: 2026-07-18T06:12:48.702Z. Eğitim aracıdır, yatırım tavsiyesi değildir.

---

## Hızlı Özet

| Alan | Değer | Kaynak |
|---|---|---|
| Fiyat | $253.04 (▲ 1.23%) | fmp:quote |
| Market Cap | $609.1B | fmp:profile |
| 52w aralık | $162.78 – $269.43 | fmp:quote |
| Bilanço | Sal 13 Ekim | fmp:earnings-history |
| EPS beklenti | $3.02 (+%8 YoY) | fmp:earnings-estimate |
| Gelir beklenti | $25.3B | fmp:earnings-estimate |
| Beat serisi | 2/4 | fmp:earnings-history |
| Rating | B+ (overall 3/5) | fmp:ratings |
| Analyst median target | $272 (+%7.5 upside) | fmp:price-target-consensus |
| MoonshotScore | 60/100 | derived |
| Council | 3/6 bullish | derived |
| Munger verdict | Fairly Valued | derived |

## Johnson & Johnson — Q1 FY2027 Beklentileri

Q1 konsensüs: gelir <strong data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvgLabel">$25.3B</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvg" title="FMP est">[FMP est]</sup>, EPS <strong data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">$3.02</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg" title="FMP est">[FMP est]</sup>. 2 çeyrek üst üste beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.beatStreakCount" title="FMP earnings">[FMP earnings]</sup>.

## Quick Take

**Skor:** B+ · **Stance:** HOLD · **Council:** 3/6 · **Moonshot:** 60

= MoonshotScore <strong>60</strong><sup class="cite" data-source="derived" data-field="moonshot.score" title="9 pillar formül">[9 pillar formül]</sup> + Council <strong>3/6</strong><sup class="cite" data-source="derived" data-field="council.bullishCount" title="6 lens kuralı">[6 lens kuralı]</sup>. Form 4: 0 işlem<sup class="cite" data-source="fmp:insider-trading" data-field="insider.txCount" title="FMP Form 4">[FMP Form 4]</sup>.

## İzleme Listesi (0 metrik)

—

## MoonshotScore Pillars

| Pillar | Score | Level | Kanıt |
|---|---|---|---|
| Revenue Growth | 3.0 | weak | Q2 vs Q3: ılımlı büyüme (+%5.5) |
| Gross Margin | 7.0 | strong | Q2: çok yüksek marj (%73.1, software/cloud kıvamı) |
| Operating Leverage | 3.0 | weak | op marj sağlıklı (%28.3) |
| Cash Runway | 10.0 | strong | FCF güçlü ($1.5B FCF, CapEx'i karşılıyor) |
| R&D Intensity | 5.0 | medium | yüksek R&D yoğunluğu (%15.4, agresif) |
| Price Momentum | 7.0 | strong | RSI 54.4 dengeli, 50g üstü |
| News Sentiment | 7.0 | strong | çoğunluk buy (65%) |

**Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula.

## Council (7-Lens)

| İsim | Stance | Bağlam |
|---|---|---|
| Ray Dalio | bull | macro · target upside +%7.5 |
| Ken Griffin | bull | flow · 50g MA üstünde |
| Jim Simons | neutral | quant · RSI 54 |
| Klarman | neutral | value · target upside +%7.5 |
| Buffett | bull | quality · ROE skor 5/5 |
| Munger | neutral | valuation · target upside +%7.5 |

**Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr.

## Munger Lens

- **Verdict:** Fairly Valued
- **Financial Health:** Moderate
- **Margin of Safety:** Weak
- **Interest Coverage:** Adequate
- **ROIC vs WACC:** Healthy

**Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget.

## Teknik Seviyeler

- **RSI(14):** 54.4 — dengeli — yön sinyali zayıf
- **50g MA:** $239 — hisse %6.0 üstünde — kısa vadeli destek
- **200g MA:** $223 — hisse %13.5 üstünde — uzun vadeli destek
- **Hacim (10g):** -%5

## Geçmiş Performans (4 Çeyrek)

| Çeyrek | EPS Actual | EPS Estimate | Sonuç | Reaction |
|---|---|---|---|---|
| Q3 FY25 | $2.80 | $2.76 | BEAT | +%0.2 |
| Q4 FY25 | $2.46 | $2.46 | MISS | +%0.2 |
| Q1 FY26 | $2.70 | $2.68 | BEAT | -%0.6 |
| Q2 FY26 | $2.90 | $2.84 | +%2.1 EPS | +%1.2 |

Q2 (15 Temmuz 2026): EPS $2.90 vs $2.84 est<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, +%2.1 beat. D+1 hareketi: +%1.2<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP D+1">[FMP D+1]</sup>. Beat'e rağmen düşüş — piyasa rehbere tepki verdi, rakam değil.

## 3 Senaryo

### Senaryo A · Beat
**Q1 EPS > $3.02 + CapEx disiplini**

Eşik: EPS > $3.02<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>.

Hedef: Median target $272<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP target]</sup> üstüne kırılma; high target $305<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.high">[FMP]</sup> üst sınır.

### Senaryo B · In-Line
**EPS ≈ $3.02 + CapEx < $1.0B**

Eşik: EPS ≈ $3.02<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>, Q1 CapEx < $1.0B<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel">[FMP]</sup>.

Hedef: Mevcut $253<sup class="cite" data-source="fmp:quote" data-field="quote.price">[FMP]</sup> ile median $272<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP]</sup> bandında konsolidasyon.

### Senaryo C · Miss
**EPS < $2.93 veya CapEx ≥ $1.0B**

Eşik: EPS < $2.93<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est×0.97]</sup>.

Hedef: Mevcut $253 SMA200 $223<sup class="cite" data-source="fmp:technical" data-field="technical.sma200">[FMP]</sup> altında, reddi sürerse $189<sup class="cite" data-source="derived" data-field="technical.sma200" data-formula="round(sma200*0.85)">[derived]</sup> destek aktive olur.

## Risk Notları

### Ana segment altı eşik
Q2: EPS $2.90 vs $2.84 beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, hisse +%1.2 D+1<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP">[FMP]</sup>.

### Backlog konsantrasyonu
Q2 earnings call'da RPO/backlog konsantrasyonu açıklanmadı.

### İçeriden işlem (insider)
Form 4 verisi tablo'da işaretli — bu hisse için sayfa varsayım üretmez.

| Yönetici | İşlem | Tutar | Tarih |
|---|---|---|---|


**Net:** — (0 işlem · 0 satış · 0 alım) · Q2 FY26

### CapEx şoku
Q2 CapEx $1.0B<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel" title="FMP cashflow">[FMP cashflow]</sup>. Q2 op margin %28.3<sup class="cite" data-source="fmp:income" data-field="income.quarters.0.operatingMargin" title="FMP op margin">[FMP op margin]</sup> — Q1'da bu seviye CapEx revize riskine duyarlı.

## Wall Street Konsensüs

- **Median target:** $272 (+%7.5 upside vs current $253)
- **High / Low:** $305 / $220
- **Buy / Hold / Sell:** 15 / 7 / 1
- **Analyst count:** 15 (last quarter), 96 all-time

## Ek Transcript Insight'ları

—

---

*Veri kaynağı: FMP (canlı sorgu, 2026-07-18), Q2 FY2026 earnings call transcript (Gemini 2.0 Flash ile TR'ye çevrildi). Eğitim aracıdır, yatırım tavsiyesi değildir.*